HIV-2 Link to AIDS in West Africa
Overview
Affiliations
To date, very little is known concerning the clinical spectrum of human immunodeficiency virus type 2 (HIV-2) infection, and the question as to whether HIV-2 will ultimately prove to be as pathogenic as human immunodeficiency virus type I (HIV-1) remains, as yet, unanswered. We reviewed the currently available reports of HIV-2 infection to assess what is known about the extent of HIV-2 pathogenicity as it compares to HIV-1 pathogenicity. There is evidence that HIV-2 is associated with AIDS. Most of this evidence, however, comes from descriptive case-report type data that do not meet the basic requirements for defining causality. The most significant problems are the lack of control groups and the absence of a documented temporal relationship with HIV-2 infection preceding the development of AIDS. Comparisons of the epidemiology and disease association between HIV-1 and HIV-2 in Africa may suggest relative pathogenic effects. Although certain comparisons between HIV-2 and HIV-1 are difficult to make, we conclude on the basis of existing data that the pathogenic effects and the natural history of HIV-2 are distinct from those of HIV-1.
The HIV-2 proviral landscape is dominated by defective proviruses.
Koofhethile C, Gao C, Chang C, Lian X, Shapiro R, Yu X AIDS. 2023; 38(3):309-316.
PMID: 37916471 PMC: 10842655. DOI: 10.1097/QAD.0000000000003776.
Diagnostic Performances of Three Rapid Diagnostic Tests for Detecting HIV Infections in Mali.
Kone B, Sarro Y, Baya B, Dabitao D, Coulibaly N, Wague M Infect Dis Diagn Treat. 2021; 3(1).
PMID: 34355138 PMC: 8336946.
Schmidt W, Loeff M, Aaby P, Whittle H, Bakker R, Buckner M Epidemiol Infect. 2007; 136(4):551-61.
PMID: 17559692 PMC: 2870829. DOI: 10.1017/S0950268807008758.
Owen S, Ellenberger D, Rayfield M, Wiktor S, Michel P, GRIECO M J Virol. 1998; 72(7):5425-32.
PMID: 9620997 PMC: 110175. DOI: 10.1128/JVI.72.7.5425-5432.1998.
Shpaer E, Mullins J J Mol Evol. 1993; 37(1):57-65.
PMID: 8395604 DOI: 10.1007/BF00170462.